BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.15% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.66% |
| 4 | Healthcare | 5.15% |
| 5 | Industrials | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
HCI Group
HCI
$2.28B
| $173K | ﹤0.01% |
2,540
-6,027
| -70% | -$412K |
|
|
HAYN
3002
DELISTED
Haynes International, Inc.
HAYN
| $173K | ﹤0.01% |
4,065
-4,360
| -52% | -$172K |
|
3003
Great Southern Bancorp
GSBC
$877M
| $173K | ﹤0.01% |
2,928
-1,516
| -34% | -$91.3K |
|
3004
Scorpio Tankers
STNG
$3.81B
| $173K | ﹤0.01% |
8,071
-268,016
| -97% | -$4.29M |
|
|
CIR
3005
DELISTED
CIRCOR International, Inc
CIR
| $172K | ﹤0.01% |
6,452
-3,004
| -32% | -$79.6K |
|
3006
1st Source
SRCE
$2.13B
| $172K | ﹤0.01% |
3,713
-3,629
| -49% | -$179K |
|
3007
Brown-Forman Class A
BF.A
$13B
| $172K | ﹤0.01% |
2,735
+1,406
| +106% | +$87.1K |
|
3008
Gates Industrial Corporation Ltd.
GTES
$7.05B
| $171K | ﹤0.01% |
11,379
+5,409
| +91% | +$84.7K |
|
3009
iShares MSCI South Africa ETF
EZA
$559M
| $170K | ﹤0.01% |
3,063
-3,100
| -50% | -$159K |
|
3010
Cass Information Systems
CASS
$742M
| $169K | ﹤0.01% |
4,589
-2,247
| -33% | -$89.6K |
|
3011
OptimizeRx
OPRX
$132M
| $168K | ﹤0.01% |
4,468
-3,605
| -45% | -$160K |
|
3012
National Healthcare
NHC
$3.47B
| $168K | ﹤0.01% |
2,390
-2,944
| -55% | -$198K |
|
|
XENT
3013
DELISTED
Intersect ENT, Inc
XENT
| $167K | ﹤0.01% |
5,966
-2,558
| -30% | -$70.1K |
|
|
GRMN
3014
CALL
Garmin
GRMN
$59.8B
| $166K | ﹤0.01% |
14
| – | – |
|
3015
Camden National
CAC
$990M
| $165K | ﹤0.01% |
3,510
-2,970
| -46% | -$147K |
|
|
SMED
3016
DELISTED
Sharps Compliance Corp
SMED
| $165K | ﹤0.01% |
27,947
-2,421
| -8% | -$15.2K |
|
|
AGS
3017
DELISTED
PlayAGS
AGS
| $165K | ﹤0.01% |
24,691
-10,383
| -30% | -$77.9K |
|
|
HUYA
3018
Huya Inc
HUYA
$547M
| $164K | ﹤0.01% |
36,739
-79,786
| -68% | -$458K |
|
3019
Invesco Ultra Short Duration ETF
GSY
$3.88B
| $164K | ﹤0.01% |
3,289
-36,358
| -92% | -$1.82M |
|
|
ECOM
3020
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $164K | ﹤0.01% |
9,869
-652
| -6% | -$12.4K |
|
3021
ANI Pharmaceuticals
ANIP
$1.72B
| $163K | ﹤0.01% |
5,798
-1,124
| -16% | -$41.9K |
|
3022
iShares Fallen Angels USD Bond ETF
FALN
$1.61B
| $161K | ﹤0.01% |
+5,804
| New | +$164K |
|
3023
CryoPort
CYRX
$750M
| $160K | ﹤0.01% |
4,597
-4,053
| -47% | -$153K |
|
|
BHR
3024
Braemar Hotels & Resorts
BHR
$139M
| $160K | ﹤0.01% |
25,852
-3,674
| -12% | -$21K |
|
3025
Covenant Logistics
CVLG
$865M
| $160K | ﹤0.01% |
14,830
-12,970
| -47% | -$146K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.